by Biocross | Jun 5, 2011 | Press release
The biotechnology spin-off Biocross is developing a laboratory test for accurate identification of Alzheimer’s disease patients. Biocross researchers are working on developing a multiparameter system, as it seems clear that a single marker is unlikely to...
